According to eFFECTOR Therapeutics's latest financial reports the company has $25.38 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $26.31 M | -47.06% |
2021-12-31 | $49.7 M | 226.64% |
2020-12-31 | $15.21 M |